We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Registers a Bigger Fall Than the Market: Important Facts to Note
Read MoreHide Full Article
In the latest trading session, UnitedHealth Group (UNH - Free Report) closed at $370.63, marking a -1.42% move from the previous day. This change lagged the S&P 500's 0.47% loss on the day. Elsewhere, the Dow saw an upswing of 0.1%, while the tech-heavy Nasdaq depreciated by 1.25%.
Heading into today, shares of the largest U.S. health insurer had lost 4.35% over the past month, lagging the Medical sector's loss of 3.97% and the S&P 500's gain of 1.15%.
The upcoming earnings release of UnitedHealth Group will be of great interest to investors. The company's earnings report is expected on October 13, 2026. The company is predicted to post an EPS of $4.12, indicating a 41.1% growth compared to the equivalent quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $111.38 billion, indicating a 1.57% decrease compared to the same quarter of the previous year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $19.85 per share and revenue of $446.78 billion. These totals would mark changes of +21.41% and -0.18%, respectively, from last year.
Investors might also notice recent changes to analyst estimates for UnitedHealth Group. These revisions help to show the ever-changing nature of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.15% increase. Right now, UnitedHealth Group possesses a Zacks Rank of #2 (Buy).
In the context of valuation, UnitedHealth Group is at present trading with a Forward P/E ratio of 18.94. For comparison, its industry has an average Forward P/E of 21.09, which means UnitedHealth Group is trading at a discount to the group.
We can additionally observe that UNH currently boasts a PEG ratio of 1.41. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. As of the close of trade yesterday, the Medical - HMOs industry held an average PEG ratio of 1.41.
The Medical - HMOs industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 45, placing it within the top 19% of over 250 industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
View the Zacks #1 Rank List
Image: Bigstock
UnitedHealth Group (UNH) Registers a Bigger Fall Than the Market: Important Facts to Note
In the latest trading session, UnitedHealth Group (UNH - Free Report) closed at $370.63, marking a -1.42% move from the previous day. This change lagged the S&P 500's 0.47% loss on the day. Elsewhere, the Dow saw an upswing of 0.1%, while the tech-heavy Nasdaq depreciated by 1.25%.
Heading into today, shares of the largest U.S. health insurer had lost 4.35% over the past month, lagging the Medical sector's loss of 3.97% and the S&P 500's gain of 1.15%.
The upcoming earnings release of UnitedHealth Group will be of great interest to investors. The company's earnings report is expected on October 13, 2026. The company is predicted to post an EPS of $4.12, indicating a 41.1% growth compared to the equivalent quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $111.38 billion, indicating a 1.57% decrease compared to the same quarter of the previous year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $19.85 per share and revenue of $446.78 billion. These totals would mark changes of +21.41% and -0.18%, respectively, from last year.
Investors might also notice recent changes to analyst estimates for UnitedHealth Group. These revisions help to show the ever-changing nature of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.15% increase. Right now, UnitedHealth Group possesses a Zacks Rank of #2 (Buy).
In the context of valuation, UnitedHealth Group is at present trading with a Forward P/E ratio of 18.94. For comparison, its industry has an average Forward P/E of 21.09, which means UnitedHealth Group is trading at a discount to the group.
We can additionally observe that UNH currently boasts a PEG ratio of 1.41. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. As of the close of trade yesterday, the Medical - HMOs industry held an average PEG ratio of 1.41.
The Medical - HMOs industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 45, placing it within the top 19% of over 250 industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.